Dexamethasone Reduces Glycolysis and Inflammation in Human Macrophages Infected With Mycobacterium avium Without Compromising Bacterial Control.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 42578819.
- Also identified by DOI 10.1093/infdis/jiag394.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Nontuberculous mycobacterial infections are associated with persistent inflammation and prolonged treatment, yet host-directed therapeutic strategies remain lacking. Using metabolic flux analysis, we show dexamethasone suppressed Mycobacterium avium-induced glycolysis in human monocyte-derived macrophages. Furthermore, dexamethasone reduced metabolic enzyme expression and proinflammatory cytokines, without affecting bacterial control in human macrophages. These findings indicate that suppression of glycolytic metabolism can occur without impacting bacterial control in human macrophages and supports further investigation of dexamethasone as a potential host-directed strategy to limit inflammation while preserving host defense in nontuberculous mycobacterial disease.